GI INNOVATION
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
GI INNOVATION
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.gi-innovation.com
Total Employee:
11+
Status:
Active
Total Funding:
31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail JsDelivr Cloudflare JS CDN JS
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Qiyu Biotech
Qiyu Biotech is an innovative macromolecular drug developer.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Employees Featured
Founder
Official Site Inspections
http://www.gi-innovation.com Semrush global rank: 3.81 M Semrush visits lastest month: 3.51 K
- Host name: 58.230.162.200
- IP address: 58.230.162.200
- Location: Daegu South Korea
- Latitude: 35.8723
- Longitude: 128.5924
- Timezone: Asia/Seoul
- Postal: 41934
More informations about "GI Innovation"
GI Innovation - Crunchbase Company Profile & Funding
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus …See details»
GI INNOVATION
Chairman, Korea Biotechnology Industry Organization (BIO) Myoung Ho Jang General of New Drug Development and Clinical Trial. Fold. Major Career. 2017-GI Innovation Founder, CSO. …See details»
GI INNOVATION
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research.See details»
GI Innovation - Products, Competitors, Financials, Employees ...
GI Innovation focuses on developing biologics for immuno-oncology and inflammation/immunology diseases. The company utilizes a platform technology, GI-SMART, …See details»
GI Innovation - VentureRadar
"GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus …See details»
GI Innovation - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 15, 2021: Series C - GI …See details»
GI Innovation - Updates, News, Events, Signals & Triggers
GI Innovation may be growing as it is part of the biotechnology industry and has been involved in securing licensing deals. The company is among the 14 Korean drugmakers that have …See details»
GI Innovation - Craft
GI Innovation (주)지아이이노베이션) is a company engaged in microbiome drug development. It focuses on immuno-oncology, inflammation, and immunology diseases. The company …See details»
GI Innovation, i-Divine to co-develop new drugs using AI
Sep 24, 2024 Through this partnership, the two companies will focus on optimizing clinical development strategies for GI Innovation’s key cancer immunotherapy pipelines, GI-102 and …See details»
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 …
GI-102 is a novel bi-specific Fc fusion protein containing the CD80 ectodomain as an. N-terminal moiety and an interleukin (IL)-2 variant as a C-terminal moiety configurated ... Lead …See details»
GI Innovation | Insights
Dec 6, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
PR ROOM - gi-innovation.com
Dec 21, 2021 South Korea's bio-venture company GI Innovation will cooperate with a domestic clinical development and research organization for the development and commercialization of …See details»
GI Innovation - Contacts, Employees, Board Members
GI Innovation is a global leader of microbiome drug development.See details»
GI Innovation secures first KRW 20 billion after listing: focus on ...
Jul 31, 2024 [by Lee, Young Sung] Innovative new drug development company GI Innovation announced on July 30 that it is raising funds for the first time since its listing in March 2023. …See details»
What is GI Innovation? Company Culture, Mission, Values
See what employees say it's like to work at GI Innovation. Salaries, reviews, and more - all posted by employees working at GI Innovation.See details»
GI INNOVATION
Aug 26, 2024 The 2024 ESMO Annual Congress, held from September 13th to 17th in Barcelona, Spain, showcased key advancements in cancer treatments. GI Innovation, focused …See details»
GI Innovation, Inc. (GI Innovation, Inc.) - 药物管线_专利_临床试验_ …
了解GI Innovation, Inc. (GI Innovation, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 21篇新闻和8篇文献，疾病领域:肿瘤，内分泌与代谢疾病，免疫系统疾病，神经系 …See details»
General Inception acquires Enable Medicine and announces …
1 day ago As a business co-founder, GI brings together domain and functional expertise, executive talent, infrastructure and development resources, and capital to ignite, nurture and …See details»
GI INNOVATION
Dec 8, 2021 GI Innovation licensed out whose deal size is total 2.3 trillion in pre-clinical trial of main pipeline, immuno-oncology GI-101(Simcere Pharmaceutical Co.Ltd., China) and allergic …See details»
GI INNOVATION
Jun 11, 2024 Next generation Immuno-oncology, GI-102 of GI Innovation, announces that its IND was approved by U.S. FDA and GI expects powerful immune activation to combine with …See details»